Bill Christiansen


I help life science innovators gain a competitive edge by performing appropriate due diligence as well as acquiring and optimizing worldwide patent assets.

Dr. Bill Christiansen advises pharmaceutical, biotechnology, clean energy and medical device companies, as well as universities, non-profit research institutions and investors, with respect to complex intellectual property matters and market exclusivity strategies.

Download full bio 


  • Asymchem Agrees to Acquire Snapdragon Chemistry 

  • Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies 

  • GGV Capital Raises $2.5 Billion Across Four Funds 

  • Celularity to Go Public Through SPAC Merger 

  • Owl Ventures Closes $585 Million in New Funds to Support Edtech 

  • View all

I've worked with a lot of patent attorneys and what distinguishes Bill above others is how deeply he learns about your business as well as your science. He knows how to position your patents to increase their value, especially relative to your competition. – Client

  • University of Washington School of Law
    JD, with honors, 1998

  • University of Notre Dame
    PhD, Biochemistry, Biophysics and Molecular Biology

  • Oregon State University
    BS, Biochemistry and Biophysics

Admissions & Credentials

Registered to practice before the United States Patent & Trademark Office (USPTO)



  • American Bar Association

  • Licensing Executives Society

  • Washington Biotechnology and Biomedical Association

  • Washington State Patent Law Association

  • American Intellectual Property Law Association

Rankings & Accolades

     Best Lawyers: Top lawyer for life sciences and patent law

    Chambers: Leading patent lawyer

    IAM Patent 1000: Top patent practitioner

    LMG Life Sciences: Leading life sciences patent lawyer

    Super Lawyers: Top 40 Washington IP lawyer